J&J Wins FDA Nod for Erleada, the First Drug for Nonmetastatic Prostate Cancer Post author:Sam Post published:February 14, 2018 Post category:BioPharma Janssen got a little love from the FDA on Wednesday. Source: BioSpace You Might Also Like Stoke Therapeutics Comes Out of Seed Mode With $40M and Ex-Sarepta CEO at Its Helm January 3, 2018 North Korean Biotech Institute Allegedly Involved in the Killing of Leader Half Brother February 21, 2017 NYC Startup Syntimmune Names Former Biogen Exec as New CEO January 2, 2018
North Korean Biotech Institute Allegedly Involved in the Killing of Leader Half Brother February 21, 2017